As reported by the authors, EB-PSMA-617 retained a high degree of internalization by tumor cells, and a prolonged time window for binding to PSMA, thus significantly increasing the tumor accumulation of the targeting agent [39]. The gene discussed is FOLH1; the disease is neoplasm.